Both copyright and Mounjaro are powerful medications helping people control obesity, but they function through unique mechanisms. copyright primarily regulates glucagon-like peptide-1 (GLP-1) receptors, encouraging insulin release and suppressing hunger . Mounjaro, on the other hand, is a dual agonist that affects both GLP-1 and glucose-dependent i